Hutch News

Hutch News

Stories tagged 'Clinical Research'

3 new projects map out immune responses to cancers

Scientists aim to gather knowledge that improves future immunotherapies

July 30, 2018 | By Susan Keown / Fred Hutch News Service

The immune system has the potential to eradicate cancer. But cancers are expert escape artists, with numerous tools for shutting down or hiding from immune attack. Three research teams at Fred Hutch have launched new projects aimed at revealing some of these secrets and laying the groundwork for developing better immune-harnessing cancer therapies, or immunotherapies.

View story >


Dr. Jen Adair honored for STEM workshop

Boys & Girls Clubs honors board president for middle school ‘Gene Therapist for a Day,’ leadership

July 5, 2018 | By Sabrina Richards / Fred Hutch News Service

The local Boys & Girls Clubs chapter recognized Adair's role in creating and hosting a Gene Therapist for a Day workshop for elementary and middle-school students.

View story >


Nanoparticles open doors to cancer-fighting CAR T cells

Tiny liposome-based drug carriers make tumors more vulnerable to targeted immunotherapy

July 2, 2018 | By Sabrina Richards / Fred Hutch News Service

Scientists at Fred Hutchinson Cancer Research Center have developed a cheap way to make cancers temporarily vulnerable to immune attack using liposome-based nanoparticles to carry immune-boosting drugs deep into tumors.

View story >


New guide helps clinicians navigate immunotherapy revolution in Merkel cell carcinoma

‘Real-world’ review accompanies new clinical care guidelines in rare skin cancer

June 28, 2018 | By Susan Keown / Fred Hutch News Service

Fred Hutchinson Cancer Research Center researchers have published a new guide to help clinicians navigate a recent revolution in care for advanced Merkel cell carcinoma, a rare and deadly skin cancer.

View story >


His immune system eradicated his melanoma. Could other patients’ bodies be taught to do the same thing?

How one man’s T cells are guiding the development of next-gen immunotherapies

June 19, 2018 | by Susan Keown / Fred Hutch News Service

Chris Pope's immune system eradicated his stage 4 melanoma on an immunotherapy clinical trial. Is it possible to genetically reprogram other patients' to do the same thing?

View story >


Dr. Joshua Hill receives Amy Strelzer Manasevit grant award

Award will help fund ‘paradigm shift’ in diagnosing post-transplant infections

June 6, 2018 | By Mary Engel / Fred Hutch News Service

Dr. Joshua Hill, a physician-researcher at Fred Hutch who studies post-transplant complications, has received one of the most coveted honors in the transplantation field.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.